Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck KGaA presents bispecific anti-ErbB antibodies for cancer therapy

June 2, 2004

Nebulized doripenem effective in P. aeruginosa pneumonia model

June 2, 2004

UCB-35440-3 relieves bronchoconstriction in vivo

June 2, 2004

Preclinical results on activity of OPC-6535 in COPD

June 2, 2004

Therapeutic benefits found with ambrisentan in PAH

June 2, 2004

EPI-12323 reduces the severity of late allergic reactions in asthmatics

June 2, 2004

PGN-0052 induces bronchodilatation in patients with mild to moderate asthma

June 2, 2004

Clinical efficacy of an olmesartan medoxomil/hydrochlorothiazide combination in hypertension

June 2, 2004

BioMarin highlights first quarter developments

June 2, 2004

Myriad Genetics achieves significant progress on many fronts during third quarter

June 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...